Dr. Naeem Tahir, MD

Oncology •  Male • Age 52

  
Dr. Tahir

Dana Farber Cancer Center

20 PROSPECT ST, FL 2 Milford, MA 01757

Make an Appointment

(508) 488-3700

Dr. Naeem Tahir, MD is an oncology specialist in Milford, MA and has been practicing for 23 years. He graduated from King Edward Medical College in 1990 and specializes in oncology, geriatric medicine, and more.


At a Glance

  • Explains conditions well Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction Patients said they were highly satisfied at this doctor's hospital. See hospitals
  • Good patient care Patients said they had exceptional care at this hospital. See hospitals

Insurance Check

Search for your insurance provider

Dr. Tahir accepts

Accepted insurance can change. Please double-check when making an appointment.

(508) 488-3700

Dr. Tahir accepts the following insurance:

Aetna
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Blue Cross Blue Shield of Louisiana
BlueConnect HMO
Blue Cross Blue Shield of Massachusetts
Preferred Blue PPO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
EmblemHealth
Health Insurance Plan of Greater New York (HIP) PPO
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
Harvard Pilgrim Health Care
Harvard Pilgrim Health Care PPO
Humana
Choice Care PPO
MultiPlan
PHCS Network PPO
Tufts Health Plan
Tufts PPO

Background Check

No malpractice claims found for Massachusetts
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Tahir's experience treating your condition or procedure

Dr. Tahir's Top Procedures and Conditions

Treatment Frequency
Blood Disorders
very high
very high

Treatment Frequency

Dr. Tahir treats Blood Disorders more than 98% of his peers

Dr. Tahir treats this condition more than 98% of his peers

Cancer
very high
very high

Treatment Frequency

Dr. Tahir treats Cancer more than 97% of his peers

Dr. Tahir treats this condition more than 97% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Lung Cancer
very high
very high

Treatment Frequency

Dr. Tahir treats Lung Cancer more than 96% of his peers

Dr. Tahir treats this condition more than 96% of his peers

Rating Includes other areas of care:

  • Adult Small Cell Lung Cancer
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Clear Cell Adenocarcinoma
  • Non-Small Cell Lung Cancer
  • Pleura Cancer
  • Small Cell Lung Cancer

Dr. Tahir's conditions and procedures:

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • Adrenal Gland Cancer
  • All Lymphoma
  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Autoimmune Diseases
  • Basal Cell Carcinoma
  • Bile Duct Cancer
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Burkitt's Lymphoma
  • Cancer
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Esophageal Cancer
  • Esophageal Diseases
  • Fallopian Tube Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gallbladder Cancer
  • Gastrointestinal Diseases
  • Graft vs Host Disease
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hemophilia
  • Hemophilia A
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kaposi's Sarcoma
  • Kidney Cancer
  • Lambert-Eaton Syndrome
  • Laryngeal Cancer
  • Larynx Conditions
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Lymphocytosis
  • Lymphoma, Large-Cell
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Tumors, Malignant
  • Melanoma
  • Merkel Cell Carcinoma
  • Multiple Myeloma
  • Mycosis Fungoides
  • Myelodysplastic Syndromes
  • Myeloma
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Penile Cancer
  • Peripheral T-Cell Lymphoma
  • Pleura Cancer
  • Pleural Cancer
  • Polycythemia Rubra Vera
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Purpura
  • Qualitative Platelet Defects (incl. Glanzmann's Thrombasthenia)
  • Reticulosarcoma
  • Retina Diseases
  • Salivary Gland Cancer
  • Secondary Malignancies
  • Sickle Cell Disease
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Diseases
  • Testicular Cancer
  • Thalassemia
  • Thoracentesis
  • Throat Cancer (Hypopharyngeal)
  • Throat Cancer (Nasopharyngeal)
  • Throat Cancer (Oropharyngeal)
  • Thrombocytosis
  • Thyroid Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Urinary Disorders
  • Uterine Cancer
  • Uterine Diseases
  • Vaginal Cancer
  • Vascular Disease
  • von Willebrand Disease
  • Vulvar Cancer

Dr. Tahir's Reviews

Likelihood to recommend Dr. Tahir

4.2

Based on 5 reviews

5 Stars
80%
(4)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
20%
(1)

Leave a review

How likely are you to recommend
Dr. Tahir?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Tahir's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Naeem Tahir, MD
RecentHighestLowestMost Helpful
Reply
As a health care professional who has worked in oncology and hospice, I can easily say how appalled I am at how he treated my father. The first meeting he appeared kind, but washed his hands of him by not providing appropriate options since treatment was "most likely" impossible. This doctor needs to learn human decency instead of waiting for another doctor to honestly review test results during an ER visit 2 weeks later and offer the option of hospice, which we got on just in time.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Naeem Tahir, MD?
Reply
He was very compassionate When I told him I would like to seek a second opinion he had no problem with that. To me that is a doctor who in confident in himself.
Was this helpful?
thumbs up icon option5
thumbs down icon option
×Post a ResponseAre you Dr. Naeem Tahir, MD?

Leave a review

How was your experience with Dr. Tahir?

About Me

Biography

Dr. Naeem Tahir, MD is an oncology specialist in Milford, MA and has been practicing for 23 years. He graduated from King Edward Medical College in 1990 and specializes in oncology, geriatric medicine, and more.

Specialties

  • Oncology
  • Geriatric Medicine
  • Hematology
  • Hematology & Oncology

Board Certifications

  • Geriatric Medicine
  • Internal Medicine
  • Medical Oncology

Education

1997
Wright St U
Residency Hospital
1995
Saint Louis University Hospital
Internship Hospital
1990
King Edward Medical College
Medical School

Awards

Locations

Practice

Dana Farber Cancer Center
20 PROSPECT ST, FL 2 Milford, MA 01757
1

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Tahir treats patients.

Learn more

81% Patient experience rating, 12% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2018, 2017)

70% Patient experience rating, 1% higher than the national average

  • Patient Safety Excellence Award™ (2019)
  • Outstanding Patient Experience Award™ (2017)

74% Patient experience rating, 5% higher than the national average